Cardiovascular toxicities of immune therapies for cancer – a scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology

By sjmartinez • August 2, 2024

Tocchetti CG, Farmakis D, Koop Y, Andres MS, Couch LS, Formisano L, Ciardiello F, Pane F, Au L, Emmerich M, Plummer C, Gulati G, Ramalingam S, Cardinale D, Brezden-Masley C, Iakobishvili Z, Thavendiranathan P, Santoro C, Bergler-Klein J, Keramida K, de Boer RA, Maack C, Lutgens E, Rassaf T, Fradley MG, Moslehi J, Yang EH, De Keulenaer G, Ameri P, Bax J, Neilan TG, Herrmann J, Mbakwem AC, Mirabel M, Skouri H, Hirsch E, Cohen-Solal A, Sverdlov AL, van der Meer P, Asteggiano R, Barac A, Ky B, Lenihan D, Dent S, Seferovic P, Coats AJS, Metra M, Rosano G, Suter T, Lopez-Fernandez T, Lyon AR. Cardiovascular toxicities of immune therapies for cancer - a scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology. Eur J Heart Fail. 2024 Aug 1. doi: 10.1002/ejhf.3340. Epub ahead of print. PMID: 39087551.

Tags: cardio‐oncology, Cardiology/Epi, cardiotoxicity, Hematology/Oncology, Immunotherapies, Publications

GLP-1 Receptor Agonist in Non-obese Patients with Type-2 Diabetes Mellitus and Heart Failure with Preserved Ejection Fraction

Khadke S, Kumar A, Bhatti A, Dani SS, Al-Kindi S, Nasir K, Virani SS, Upadhyay J, Garcia-Banigan DC, Abraham S, Husami R, Kong Y, Labib[...]

Resolution of ventricular tachycardia and cardiac inflammation following treatment in chronic Chagas disease

Malik A, Jiang M, Muñoz G, Meymandi S, Bradfield JS, Hayase J. Resolution of ventricular tachycardia and cardiac inflammation following treatment in chronic Chagas disease.[...]

Transcatheter Edge-to-Edge Repair in Patients With Complex Tricuspid Valve Anatomy

Adams DH, Tang GHL, Whisenant BK, Kodali SK, Singh GD, Fam NP, Kar S, Price MJ, Spies C, Schwartz JG, Makkar RR, Tadros P, Asgar[...]